Drug Profile
Lyothyronine
Alternative Names: NRP 409; TriiodothyronineLatest Information Update: 23 Oct 2021
Price :
$50
*
At a glance
- Originator New River Pharmaceuticals
- Class Amino acids; Small molecules; Thyronines
- Mechanism of Action Thyroid hormone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypothyroidism
Most Recent Events
- 08 Jan 2019 Shire has been acquired and merged into Takeda
- 02 May 2008 Discontinued - Preclinical for Hypothyroidism in USA (unspecified route)
- 04 Jul 2006 New River Pharmaceuticals has filed an IND with the US FDA for primary hypothyroidism